Expression levels of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and focal adhesion kinase in patients with multiple myeloma and their relationship to clinical stage and extramedullary infiltration

Leukemia and Lymphoma

Volumn 53, Issue 6, 2012, Pages 1162-1168

  Wang, Su Yun ^a   Hao, Hong Ling ^a   Deng, Kai ^b   Li, Yan ^a   Cheng, Zhi Yong ^c   Lv, Chao ^a   Liu, Zhi Miao ^a   Yang, Jie ^a   Pan, Ling ^d,e  

^a HEBEI GENERAL HOSPITAL   (China)

^b Department of Orthopedics ^*  (China)

^c Department of Hematology   (China)

^d HEBEI MEDICAL UNIVERSITY   (China)

^e SICHUAN UNIVERSITY   (China)

Author keywords

Clinical stage; Extramedullary infiltration; FAK; Multiple myeloma; PTEN

Indexed keywords

FOCAL ADHESION KINASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; FLUORESCENCE QUANTITATIVE POLYMERASE CHAIN REACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIC INFILTRATION; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PTEN PHOSPHOHYDROLASE;

EID: 84861360634     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.647311     Document Type: Article

References (38)

1. Witzig T, Dhodapkar M, Kyle R, et al. Quantifi cation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 1993;72:108-113. (Pubitemid 23182058)
2. Witzig T, Gertz MA, Lust JA, et al. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood 1996;88:1780-1787. (Pubitemid 26307075)
3. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314. (Pubitemid 24046692)
4. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-66. (Pubitemid 26110755)
5. Bao H, Jiang M, Zhu M, et al. Overexpression of annexin II aff ects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol 2009;90:177-185.
6. Ullmannova-Benson V, Guan M, Zhou X, et al. DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway. Leukemia 2009;23:383-390.
7. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-1947. (Pubitemid 27148818)
8. Steck PA, Pershouse MA, Jasser SA, et al. Identifi cation of a candidate tumor suppressor gene MMACI at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-362. (Pubitemid 27147102)
9. Myers MP, Stolarov JP, Eng C, et al. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specifi city phosphotase. Proc Natl Acad Sci USA 1997;94:9052-9057.
10. Dahia PL, Aguiar RC, Alberta J, et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum Mol Genet 1999;8: 185-193. (Pubitemid 29054260)
11. Yilmaz OH, Valdez R, Theisen BK, et al. PTEN dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006;441:475-482. (Pubitemid 44050144)
12. Liu YL, Castleberry RP, Emanuel PD. PTEN defi ciency is a common defect in juvenile myelomonocytic leukemia. Leuk Res 2009;33:671-677.
13. Xu Q, Simpson SE, Scialla TJ, et al. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 2003;102:972-980. (Pubitemid 36917792)
14. Montiel-Duarte C, Cordeu L, Agirre X, et al. Resistance to imatinib mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leuk Res 2008;32:709-716. (Pubitemid 351330173)
15. Ge NL, Rudikoff S. Expression of PTEN in PTEN-defi cient multiple myeloma cells abolishes tumor growth in vivo. Oncogene 2000;19:4091-4095.
16. Choi Y, Zhang J, Murga C, et al. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 2002;21:5289-5300. (Pubitemid 34948140)
17. Sakai A, Th ieblemont C, Wellmann A, et al. PTEN gene alterations in lymphoid neoplasms. Blood 1998;92:3410-3454.
18. Butler MP, Wang SI, Chaganati RSK, et al. Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. Genes Chromosomes Cancer 1999;24:322-327. (Pubitemid 29115870)
19. Aggerholm A, Gronbaek K, Guldberg P, et al. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. Eur J Haematol 2000;65:109-113. (Pubitemid 30615084)
20. Zhang J, Choi Y, Mavromatis B, et al. Preferential killing of PTENnull myelomas by P13K inhibitors through Akt pathway. Oncogene 2003;22:6289-6295. (Pubitemid 37281658)
21. Hyun T, Yam A, Pece S, et al. Loss of PTEN expression leading to high Akt activation in human multiple myelomas. Blood 2000;96: 3560-3568.
22. Chang H, Qi XY, Claudio J, et al. Analysis of PTEN deletions and mutations in multiple myeloma. Leuk Res 2006;30:262-265. (Pubitemid 43053219)
23. Wang S, Cheng Z, Yang X, et al. Effect of wild type PTEN gene on proliferation and invasion of multiple myeloma. Int J Hematol 2010;92:83-94.
24. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999;71:435-478. (Pubitemid 29156312)
25. Canel M, Secades P, Garzón -Arango M, et al. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression. Br J Cancer 2008;98:1274-1284. (Pubitemid 351481672)
26. Tamura M, Gu J, Danen EH, et al. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 1999;274:20693-20703.
27. Smith A, Wisloff F, Samson D. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 2006;132: 410-451.
28. Cheng ZY, Guo XL, Yang XY, et al. PTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathway. J Exp Clin Cancer Res 2008,27:87.
29. Zhangj, Grindley JC, Yin T, et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006;441:518-522. (Pubitemid 44050154)
30. Gauffi n F, Diff ner E, Gustafsson B, et al. Expression of PTEN and SHP1, investigated from tissue microarrays in pediatric acute lymphoblastic leukemia. Pediatr Hematol Oncol 2009;26:48-56.
31. Silva A, Yunes JA, Cardoso BA, et al. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J Clin Invest 2008,118:3762-3774.
32. Shi Y, Gera J, Hu L, et al. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779. Cancer Res 2002;62: 5027-5034. (Pubitemid 34984430)
33. Pene F, Claessens YE, Muller O, et al. Role of the phosphatidylinositol 3-kinase/AKT and mTOR/P70S6-kinase pathways in the prolifer ation and apoptosis in multiple myeloma. Oncogene 2002;21: 6587-6597. (Pubitemid 35177037)
34. Li J, Xiong WJ, Luo SK, et al. Expression of PTEN mRNA in mononuclear cells of bone marrow of multiple myeloma. Chin J Clin Oncol Rehabil 2004;11:398-400.
35. McCampbell AS, Broaddus RR, Loose DS, et al. Overexpression of the insulin-like growth factor I receptor and activation of the AKT path way in hyperplastic endometrium. Clin Cancer Res 2006;12:6373-6378. (Pubitemid 44799707)
36. Kotelevets L, van Hengel J, Bruyneel E, et al. The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness. J Cell Biol 2001;155:1129-1135. (Pubitemid 34286264)
37. Schlaepfer DD, Mitra SK. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 2004;14:92-101. (Pubitemid 38167483)
38. Haier J, Nicolson GL. PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fl uid fl ow. Oncogene 2002,21:1450-1460.